CLECKHEATON GROUP PRACTICE
CROSS CHURCH STREET, CLECKHEATON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 7 | 9 | 77.8% | |
| HF 4 | 2011 | 9 | 11 | 81.8% | |
| HF 4 | 2012 | 8 | 9 | 88.9% | |
| HF 4 | 2013 | 12 | 12 | 100.0% | |
| HF004 | 2014 | 11 | 11 | 100.0% | |
| HF004 | 2015 | 13 | 13 | 100.0% | |
| HF004 | 2016 | 16 | 16 | 100.0% | |
| HF004 | 2017 | 17 | 17 | 100.0% | |
| HF004 | 2018 | 16 | 17 | 94.1% | |
| HF004 | 2019 | 35 | 37 | 94.6% | |
| HF004 | 2020 | 32 | 34 | 94.1% | |
| HF006 | 2021 | 37 | 37 | 100.0% | |
| HF006 | 2022 | 44 | 44 | 100.0% | |
| HF006 | 2023 | 45 | 45 | 100.0% |
